ADHD Telehealth Prescribing in 2026: DEA Extension and What Happens When It Expires
Quick Summary
The DEA extended COVID-era telehealth prescribing flexibilities through December 31, 2026. Nearly half of the 15.5 million U.S. adults with ADHD have used telehealth, and 30.5% obtained prescriptions remotely. If rules expire, patients face a return to mandatory in-person visits.
한국어 요약 보기
DEA가 코로나 시대 원격진료 처방 유연성을 2026년 12월 31일까지 연장했습니다. ADHD 성인 1,550만 명 중 거의 절반이 원격진료를 이용했으며, 30.5%가 원격으로 처방을 받았습니다. 규정 만료 시 대면 진료 의무화로 돌아갑니다.
Millions of Americans with ADHD receive their prescriptions through telehealth. That access depends on temporary rules set to expire at the end of 2026. Understanding the timeline is critical for treatment planning.
The Current Rules
Source: Pexels
The DEA issued a fourth temporary extension of COVID-era telehealth flexibilities through December 31, 2026 (Holland & Knight). Providers can prescribe Schedule II stimulants like Adderall and Vyvanse via video without an in-person visit. In 2024 alone, over 7 million controlled substance prescriptions were issued through telemedicine (STAT News).
Who Relies on Telehealth
Source: Pexels
CDC data shows 15.5 million U.S. adults have ADHD, and 46% have used telehealth for ADHD services (CDC MMWR). 30.5% obtained medication prescriptions remotely since March 2020. A Mass General Brigham study of 7,944 patients found no increased substance use disorder risk from telehealth prescribing (Mass General Brigham).
What Happens If Rules Expire
Without permanent rules, regulations revert to the Ryan Haight Act of 2008 (CalTRC). That means an in-person visit before any controlled substance telehealth prescription. Proposed permanent rules would require providers to issue at least 50% of prescriptions after in-person visits (STAT News). For patients in rural areas or provider shortage zones, this could mean significantly higher costs and longer wait times.
Conclusion
Telehealth has transformed ADHD care access, but its future remains uncertain beyond 2026. If you rely on telehealth for ADHD treatment, consider establishing an in-person provider relationship now. Use our cost calculator to compare telehealth and in-person treatment costs.
Related Articles
ADHD Coaching vs Therapy: Cost Comparison and What Actually Works
Compare ADHD coaching ($75-$200/session) vs CBT therapy ($100-$250/session). See insurance coverage differences, clinical evidence, and which option fits your needs.
DiagnosisADHD Diagnosis Cost Without Insurance: What You'll Actually Pay in 2026
ADHD diagnosis without insurance costs $149 to $7,000+ in 2026. Compare psychiatrist, psychologist, telehealth, FQHC, and university clinic prices with step-by-step guidance.
DiagnosisAdult ADHD Testing: What to Expect and How Much It Costs in 2026
A complete guide to adult ADHD testing in the US. Learn what each evaluation step involves, who can diagnose, CPT billing codes, red flags, and cost by assessment type.